newsfilter
← Latest News
GlobeNewswire·

INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic

  • INVO Fertility announced the adoption of time-lapse incubation technology at its Wisconsin clinic on March 05, 2026.
  • The integration aims to enhance laboratory excellence, clinical quality, & patient-centered care across the company's growing network.
  • COO April McGhee stated the technology provides embryology teams with enhanced tools while maintaining a focus on thoughtful, patient-centered solutions.
  • Key patient benefits include continuous embryo monitoring in a stable environment, improved embryo selection through "mini-movie" reviews, & the provision of video records to increase patient engagement.
  • The technology is FDA-cleared, reflecting INVO's commitment to safety, quality, & clinical rigor.
  • CEO Steve Shum emphasized an intentional approach to innovation that enhances outcomes while expanding access to fertility care.
  • INVO Fertility operates four US-based fertility clinics & continues to sell & distribute its proprietary INVOcell device for intravaginal culture procedures.
  • The company maintains a strategy of building, acquiring, & operating clinics to offer accessible assisted reproductive technology.